Use the Back button in your browser to see the other results of your search or to select another record.
Effects of aerobic dance training on blood pressure in individuals with uncontrolled hypertension on two antihypertensive drugs: a randomized clinical trial |
Maruf FA, Akinpelu AO, Salako BL, Akinyemi JO |
Journal of the American Society of Hypertension 2016 Apr;10(4):336-345 |
clinical trial |
6/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: No; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
There is a dearth of reports on possible additive blood pressure (BP)-reducing effect of aerobic exercise on antihypertensive drug in humans. This study investigated the additive BP-reducing effect of aerobic exercise on BP in individuals with uncontrolled hypertension. In this 12-week double-blind study, 120 new-diagnosed individuals with mild-to-moderate hypertension were randomized to receive coamilozide plus 5/10 mg of amlodipine plus aerobic dance or coamilozide plus 5/10 mg of amlodipine alone. Forty-five and 43 participants in exercise and control groups, respectively, completed the 12-week intervention. Addition of aerobic exercise to antihypertensive drug therapy significantly reduced systolic BP (7.1 mmHg (95% confidence interval 5.0 to 9.3); p < 0.001) and diastolic BP (1.7 mmHg (95% confidence interval: 0.4 to 3.0); p = 0.009) at 12 weeks. BP control rate differed significantly between exercise (53.9%) and control (35.3%) groups, p < 0.001. Postintervention, proportion of participants in exercise group who had their number of antihypertensive drug reduced to one (20.3%) differed from that in control group (11.1%); (Chi2 = 11.0; p = 0.001). Combination of aerobic dance and antihypertensive drugs reduces number of antihypertensive drugs needed to achieve BP control and enhances BP control in individuals with hypertension on two antihypertensive drugs.
|